When we examine the expression of Rap1B in ECs from tumors in lung, colorectal, and ovarian cancer patients using publicly available single-cell RNA sequencing (scRNAseq) data, we find that its levels are notably higher in tumor ECs compared to their non-tumor counterparts [106,107]. The gene discussed is RAP1B; the disease is neoplasm.